These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28786030)

  • 1. Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats.
    Simmons SJ; Martorana R; Philogene-Khalid H; Tran FH; Gentile TA; Xu X; Su S; Rawls SM; Muschamp JW
    Psychopharmacology (Berl); 2017 Nov; 234(21):3207-3215. PubMed ID: 28786030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.
    Simmons SJ; Gregg RA; Tran FH; Mo L; von Weltin E; Barker DJ; Gentile TA; Watterson LR; Rawls SM; Muschamp JW
    Addict Biol; 2018 Jan; 23(1):102-110. PubMed ID: 27910188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active vaccination reduces reinforcing effects of MDPV in male Sprague-Dawley rats trained to self-administer cocaine.
    McClenahan SJ; Gunnell MG; Owens SM; Fantegrossi WE
    Psychopharmacology (Berl); 2020 Sep; 237(9):2613-2620. PubMed ID: 32500210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).
    Watterson LR; Kufahl PR; Nemirovsky NE; Sewalia K; Grabenauer M; Thomas BF; Marusich JA; Wegner S; Olive MF
    Addict Biol; 2014 Mar; 19(2):165-74. PubMed ID: 22784198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine.
    Gentile TA; Simmons SJ; Barker DJ; Shaw JK; España RA; Muschamp JW
    Addict Biol; 2018 Jan; 23(1):247-255. PubMed ID: 28419646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect.
    Simmons SJ; Gentile TA
    Brain Res; 2020 Mar; 1731():146164. PubMed ID: 30796894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats.
    Gannon BM; Sulima A; Rice KC; Collins GT
    J Pharmacol Exp Ther; 2018 Mar; 364(2):359-366. PubMed ID: 29217539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDPV self-administration in female rats: influence of reinforcement history.
    Doyle MR; Sulima A; Rice KC; Collins GT
    Psychopharmacology (Berl); 2021 Mar; 238(3):735-744. PubMed ID: 33236170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats.
    Aarde SM; Creehan KM; Vandewater SA; Dickerson TJ; Taffe MA
    Psychopharmacology (Berl); 2015 Aug; 232(16):3045-55. PubMed ID: 25925780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual Differences in the Relative Reinforcing Effects of 3,4-Methylenedioxypyrovalerone under Fixed and Progressive Ratio Schedules of Reinforcement in Rats.
    Gannon BM; Galindo KI; Rice KC; Collins GT
    J Pharmacol Exp Ther; 2017 Apr; 361(1):181-189. PubMed ID: 28179474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).
    Sewalia K; Watterson LR; Hryciw A; Belloc A; Ortiz JB; Olive MF
    Neuropharmacology; 2018 May; 134(Pt A):36-45. PubMed ID: 29183686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Contingent and Noncontingent Drug Histories on the Development of High Levels of MDPV Self-Administration.
    Doyle MR; Sulima A; Rice KC; Collins GT
    J Pharmacol Exp Ther; 2021 Nov; 379(2):108-116. PubMed ID: 34413199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDPV "high-responder" rats also self-administer more oxycodone than their "low-responder" counterparts under a fixed ratio schedule of reinforcement.
    Gannon BM; Rice KC; Murnane KS
    Psychopharmacology (Berl); 2021 Apr; 238(4):1183-1192. PubMed ID: 33484299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters.
    Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats.
    Aarde SM; Huang PK; Creehan KM; Dickerson TJ; Taffe MA
    Neuropharmacology; 2013 Aug; 71():130-40. PubMed ID: 23597511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats.
    Aarde SM; Huang PK; Dickerson TJ; Taffe MA
    Psychopharmacology (Berl); 2015 Jun; 232(11):1867-77. PubMed ID: 25424056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats.
    Risca HI; Baker LE
    Psychopharmacology (Berl); 2019 Mar; 236(3):963-971. PubMed ID: 30554256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys.
    Collins GT; Sulima A; Rice KC; France CP
    Psychopharmacology (Berl); 2019 Dec; 236(12):3677-3685. PubMed ID: 31346629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-administration of the synthetic cathinone MDPV enhances reward function via a nicotinic receptor dependent mechanism.
    Geste JR; Pompilus M; Febo M; Bruijnzeel AW
    Neuropharmacology; 2018 Jul; 137():286-296. PubMed ID: 29778945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).
    Hicks C; Gregg RA; Nayak SU; Cannella LA; Schena GJ; Tallarida CS; Reitz AB; Smith GR; Rawls SM
    Psychopharmacology (Berl); 2017 Jun; 234(11):1671-1681. PubMed ID: 28251297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.